Alaunos Therapeutics TCRT
NASDAQ TCRT
$0.93 +0.04 (+4.91%)
As of: Oct 1, 2026 · 9:36 AM EDT

Alaunos Therapeutics (TCRT) Receivables - Other (2020 - 2021)

Updated

Alaunos Therapeutics' Receivables - Other came in at $1.1 million for Q3 2021, down 85.5% from the prior quarter.

Analysis

Alaunos Therapeutics (TCRT) Receivables - Other (2020 - 2021) Analysis & Trends

At the end of FY2020, Alaunos Therapeutics' Receivables - Other was $4.7 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Alaunos Therapeutics 2.19 Mn -1.61 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 1.10 Mn
Jun 30, 2021 7.60 Mn
Dec 31, 2020 4.70 Mn
API Access

Alaunos Therapeutics Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=TCRT&period=max&api_key=YOUR_API_KEY